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ABSTRACT 
Objective: Histones are the most abundant proteins associated with the eukaryotic DNA. The N-terminal tails of these histones are subjected to 
modifications primarily by two enzymes namely, Histone acetyl transferases (HATs) and Histone deacetylases (HDACs). HDACs help in the 
regulation of the acetylation of histones and the condensation of the chromatin in its sTable form. HDACs are considered as one of the promising 
targets in cancer biology studies. HDAC9 is a class II member of HDAC family and they are associated with many neurological disorders and a 
variety of cancers. The 3D structure of this HDAC9(Q9UKV0) was not published. Thus, the aim of this study was to develop and validate the model 
structure of HDAC9 (Q9UKV0) using bioinformatics tools. 
Methods: The Physiochemical characterization was carried out using Ex PASy Prot Param tool, the Functional characterization using Cysteine 
Recognition Server and HMMTOP Server and Molecular Modeling using I-TASSER. Model Refinement, Validation and verification are carried out 
using SPDBV, RAMPAGE Server and ERRAT Server respectively.  
Result and Conclusion: This3D model of HDAC9 now can be further used to target drug discovery studies related to HDAC9 neurological disorders 
and a variety of cancers. 
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INTRODUCTION 
Histones are the most abundant proteins associated with the 
eukaryotic DNA. Eukaryotic cells contain histones-H1, H2A, H2B, H3 
and H4. Histones H2A, H2B, H3 and H4 are the core histones and 
form the protein core around which the nucleosomal DNA is 
wrapped around while H1 is the linker histone. When histones are 
isolated from cells, their N-terminal tails are modified with small 
molecules. Lysines are acetylated or methylated while serines are 
phosphorylated. Histone modifications are mediated by specific 
enzymes namely, Histone acetyl transferases (HATs) and histone 
deacetylases (HDACs). HATs are responsible for acetylation of the 
lysines while HDACsremoves these modifications. [1] Due to their 
critical role in regulation of chromatin structure and gene 
expression, HDACs are considered as a major candidate for drug 
targets [2, 3]. HDAC inhibitors are specific toward tumor cells. That 
is the reason why they are used as anticancer drugs [4]. 
Histone deacetylases are comprised of a family of 18 genes. These 
are furthered divided into 4 classes, namely-class I, class II, class III 
and class IV, based on their homology to their yeast ortho logs [5, 6]. 
Class I HDACs are closely related to yeast RPD3 and comprise 
HDAC1, HDAC2, HDAC3 and HDAC8. Class II HDACs are related to 
yeast HDA1 and are subdivided into subclass IIa (HDAC4, HDAC5, 
HDAC7 and HDAC9) and subclass IIb (HDAC6 and HDAC10). Class III 
HDACs consist of seven sirtuins [7], which require the NAD+cofactor 
for activity. Class IV contains only HDAC11. HDACs from the classical 
family are dependent on Zn2+for deacetylase activity. Inhibitors of 
Zn2+
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-dependent HDACs are inducers of transformed cell growth 
arrest and cell death and are identified as inhibitors of HDAC activity 
[8]. The HDAC9 gene is located on chromosome 7p21 [9]. This 
region is associated with many neurological disorders and a variety 
of cancers. Due to alternative splicing, HDAC9 encodes a variety of 
multiple protein isoforms. The most common HDAC9 isoform 
contains 1011 amino acids. It has a molecular mass of 111.3 kDa and 
an isoelectric point of 6.41 [10,11]. HDAC9 plays an important role 
in heart development [12] and also control the fate of regulatory T-
cells[13, 14]. Currently there is no 3D structure available for HDAC9 
(Q9UKV0). Therefore, the aim of this study was to build a HDAC9 
(Q9UKV0) 3D model using bioinformatics tools. This HDAC model 
then can be further used for docking studies. These studies can 
provide valuable information regarding the binding sites of receptor 
which are very crucial elements for ligand binding. 
The 3D structure of HDAC9 (Q9UKV0) was unavailable in Uni Prot 
KB Databank. Its FASTA sequence was retrieved from Uni Prot KB. 
This sequence was then subjected to various bioinformatics tools to 
predict its physiochemical and functional characterization. The best 
model was selected based on the confidence score. The refined and 
validated model can further be used for various drug discovery 
studies. 
Sequence retrieval and physiochemical characterization 
The query sequence of HDAC9 with the accession id Q9UKV0 was 
retrieved from UniProtKB. Table1 shows the HDAC9 query sequence 
having 1011 residues. The Physiochemical characterization of 
Q9UKV0 was determined using ExPASyProtParam tool [15]. Table 2 
shows the results of Physiochemical characterization of HDAC9 
using ExPASy’s Prot Paramtool. 
Functional characterization 
The Functional Characterization of Q9UKV0 was determined using 
Cysteine Recognition Server [16]. Table 3 shows the result of Functional 
characterization of HDAC9 using CYS_REC Server. Table 4 shows the 
Amino acid Composition of HDAC9. Transmembrane region prediction 
was carried out using HMMTOP Server [17]. Table 5 shows the Trans 
Membrane Region of HDAC9 as predicted by HMMTOP Server. 
Model building and model refinement 
The three dimensional structure of HDAC9 was modeled using I-
TASSER model workspace [18-20]. Table 6 shows the Top 10 
templates used by I-TASSER to build the model. These templates 
were selected using a meta-threading approach. Table 7 shows the 
result of I-TASSER modeling score. The best among the resultant 
modeled structures was then selected depending on confidence 
score. Fig. 1 shows the I-TASSER 3D Modeled structure of HDAC9 
using UCSF Chimera [21]. 
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I-TASSER server is an on-line platform for protein structure and 
function predictions. 3D models are built based on multiple-threading 
alignments by LOMETS and Iterative template fragment assembly 
simulations; function insights are derived by matching the 3D models 
with BioLiP protein function database. Fig. 2 shows the energy 
minimization of the modeled structure using Swiss-Pdb Viewer [22]. 
 
Table 1: It shows the HDAC9 query sequence having 1011 residues. 












Table 2: It shows the results of Physiochemical Characterization of HDAC9 using Ex PASy’s ProtParamtool 
Length Mol. wt. -pI +R -R Extinction coefficient Instability Index Aliphatic Index GRAVY 
1011 111297.0 6.40 103 115 44975 55.41 83.06 -0.524 
 
Table 3: It shows the result of Functional Characterization of HDAC9 using CYS_REC 
No of Cys residues Position Score 
1 353 -5.4 
2 534 -9.0 
3 646 -19.5 
4 648 -23.0 
5 677 -23.4 
6 731 -17.6 
7 757 -26.2 
8 793 -23.1 
9 932 -25.1 
10 962 -21.3 
11 968 -7.4 
 
11 cysteins are found in positions The most probable pattern of pairs 
353 534 646 648 677 731 757 793 932 962 968 534-968, 646-731 
 
Table 4: It shows the Amino acid composition of HDAC9 
Name of amino acid No. of amino acid Percentage of amino acid 
Ala (A) 67 6.6% 
Arg (R) 47 4.6% 
Asn (N) 32 3.2% 
Asp (D) 43 4.3% 
Cys (C) 11 1.1% 
Gln (Q) 85 8.4% 
Glu (E) 72 7.1% 
Gly (G) 68 6.7% 
His (H) 41 4.1% 
Ile (I) 40 4.0% 
Leu (L) 115 11.4% 
Lys (K) 56 5.5% 
Met (M) 23 2.3% 
Phe (F) 22 2.2% 
Pro (P) 70 6.9% 
Ser (S) 94 9.3% 
Thr (T) 48 4.7% 
Trp (W) 4 0.4% 
Tyr (Y) 15 1.5% 
Val (V) 58 5.7% 
Pyl (O) 0 0.0% 
Sec (U) 0 0.0% 
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Table 5: It shows the Trans membrane Region of HDAC9 as predictedby HMMTOP 
Protein Length N-terminus Number of transmembrane helices Transmembrane helices 
HDAC9 1011 IN 1 789-805 
 
Model validation and verification 
The refined model was validated by RAMPAGE Server by verifying the 
parameter of Ramachandran plot quality [23]. Fig. 3 shows the 
Ramachandran plot of the modeled HDAC9. The summary of the 
model building and model quality assessment are as shown in Table 8. 
Verification of the refined model was done using ERRAT [24]. 
ERRAT is a protein structure verification algorithm that is especially 
well-suited for evaluating the progress of crystallographic model 
building and refinement. The program works by analyzing the 
statistics of non-bonded interactions between different atom types. 
A single output plot is produced that gives the value of the error 
function vs. Position of a 9-residue sliding window. By comparison 
with statistics from highly refined structures, the error values have 
been calibrated to give confidence limits. Fig. 4 shows the results of 
ERRAT showing the error value. 
RESULTS AND DISCUSSION 
Physiochemical characterization  
The Physiochemical Characterization was carried out using ExPA Sy 
Prot Paramtool. The computed isoelectric pointcan be useful for 
developing the buffer system which can be used for the purification 
using the isoelectric focusing method. Extinction coefficient values 
for protein at 280 nm was found to be44975 M-1 cm-1
Functional characterization 
, this indicates 
the presence of higher concentration of Tyr and Trp. Instability 
index was found to be 55.41 which is beyond 40. This indicates that 
the protein is slightly un  table. Higher value of aliphatic index shows 
that the protein is Table for wide range of temperature indicating 
greater amount of aliphatic to aromatic residues. The very low 
GRAVY index of protein infers that this protein could result in a 
better interaction with water. 
The CYS_REC result shows the presence of two disulphide bond. This 
indicates that the stability of protein might be increased due to this 
along with non-covalent interactions. Table 4 shows the Amino acid 
composition of HDAC9. Higher values of Lys, Leu, Serine indicates 
that the amino acids have a high chance of forming the helix and 
alpha helixes are dominant in these proteins. Trans membrane 
region predation was carried out using HMMTOP Server. 
Model building 
The three dimensional structure of HDAC9 was modeled using I-
TASSER model workspace using a meta-threading approach. The 
best among the resultant modeled structures was selected 
depending on the confidence score. 
The top ten templates used for building the model using I-TASSER 
were 2vqjA, 2vqjA, 3c10A, 2pqpA, 2pqpA, 2vqjA, 2pqpA, 3c10A, 
2vqjA and 2nvrA (Table 6). 
 
Table 6: It shows the Top 10 templates used by I-TASSER to build the model 
Rank PDB Hit Iden1 Iden2 Cov. Norm. Z-score 
1 2vqjA 0.74 0.28 0.38 2.35 
2 2vqjA 0.73 0.28 0.38 4.82 
3 3c10A 0.69 0.26 0.38 2.99 
4 2pqpA 0.69 0.26 0.38 4.96 
5 2pqpA 0.69 0.26 0.38 3.71 
6 2vqjA 0.74 0.28 0.38 3.95 
7 2pqpA 0.69 0.26 0.38 5.31 
8 3c10A 0.67 0.00 0.37 7.68 
9 2vqjA 0.74 0.28 0.38 2.79 
10 2nvrA 0.69 0.26 0.38 3.89 
 
Rank of templates represents the top ten threading templates used 
by I-TASSER. Ident1 is the percentage sequence identity of the 
templates in the threading aligned region with the query sequence. 
Ident2 is the percentage sequence identity of the whole template 
chains with query sequence. Cov. represents the coverage of the 
threading alignment and is equal to the number of aligned residues 
divided by the length of query protein. Norm. Z-score is the 
normalized Z-score of the threading alignments. Alignment with a 
Normalized Z-score >1 mean a good alignment and vice versa. Table 
7 shows the result of I-TASSER modeling score. 
 
Table 7: It shows the result of I-TASSER modeling score 
Name C-score Exp. TM-Score Exp. RMSD No. of decoys Cluster density 
Model1: -2.12 0.46+-0.15 14.3+-3.8 94 0.0223 
Model2: -2.16   80 0.0215 
Model3: -2.27   78 0.0193 
Model4: -2.33   63 0.0181 
Model5: -2.49   60 0.0155 
 
C-score is a confidence score for estimating the quality of the 
predicted models by I-TASSER. It is calculated based on the 
significance of threading template alignments and the convergence 
parameters of the structure assembly simulations. C-score is 
typically in the range of (-5, 2), where a C-score of higher value 
signifies a model with a high confidence and vice-versa. 
TM-score and RMSD are known standards for measuring the 
structural similarity between two structures which are usually used 
to measure the accuracy of structure modeling when the native 
structure is known. A TM-score >0.5 indicates a model of the correct 
topology and a TM-score<0.17 means a random similarity. This 
cutoff does not depend on the protein length. 
Here we only report the quality prediction (TM-score and RMSD) for 
the first model, because it was found that the correlation between C-
score and TM-score is weak for lower rank models. However, the C-
score of all models is listed just for a reference. The first model was 
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found to be the best out of the others modelled by I-TASSER. It has a 
C-score of -2.12 which is the highest among the rest. A higher C-
score value signifies a model with a high confidence. The TM-score is 
0.31- 0.61 which indicates a correct topology. Fig. 1shows the 
modeled structure of HDAC9 using UCSF Chimera. 
 
 
Fig. 1: It shows the I-TASSER 3-D Modeled structure of HDAC9 
using UCSF Chimera 
Other softwares which are available for model building include Swiss-
Pdb Viewer, PHYRE2, M4T server, ModWeb, HMM Modellor, RaptorX 
etc. These softwares were not used to build the model for HDAC9. This 
was because the total coverage for these servers and softwares was very 
low (<50%) because of which the authentication of the modelled 
structure was low. Due to this limitation, I-TASSER was used to model 
the structure of HDAC9 with a higher confidence score. The total 
coverage was only 34% in the case of PHYRE2. This means that only 342 
residues of the 1011 residues were modeled. While in the case of I-
TASSER the confidence score was -2.12 which is in the range of (-5, 2). 
Model refinement 
Energy Minimization of the structure was done using Swiss-Pdb Viewer 
(Fig.2). Computations were done in vacuo with the GROMOS96 43B1 
parameters set, without reaction field. For more information about 
GROMO96, refer to: W. F. van Gunsteren et al (1996) in Biomolecular 
simulation: the GROMOS96 manual and user guide; (http: //iqc. ethz. 
ch/gromos). HDAC9 has torsion of 6111.165, electrostatic energy -
25124.33 KJ/mol and total energy -20914.396 KJ/mol. 
Model validation and verification 
The refined model was validated by RAMPAGE Server by verifying 
the parameter of Ramachandran plot quality (Fig.3). Verification of 
the refined model was carried out by ERRAT (Fig.4). 
 
 
Fig. 2: It shows the Energy minimization of the modeled structure using Swiss-PdbViewer 
 
Table 8: It shows the Plot statistics of the modeled HDAC9 
Plot Analysis 
Number of residues in favored region (~98.0% expected) 841 (83.3%) 
Number of residues in allowed region (~2.0% expected) 120 (11.9%) 
Number of residues in outlier region 48 (4.8%) 
Samant et al. 




Fig. 3: It shows the Ramchandran plot of the modeled HDAC9 
 
ERRAT is a program for verifying protein structures determined by 
crystallography. The error values are plotted as a function of the 
position of a sliding 9-residue window. The error function is based 
on the statistics of non-bonded atom-atom interactions in the 
reported structure as compared to that of a database of reliable 
high-resolution structures. The overall quality factor was found to 




Fig. 4: It shows the result of ERRAT showing the error value 
 
CONCLUSION 
HDACs play a major role in regulation of chromatin structure and 
gene expression. Till now, no 3D model structure was available for 
HDAC9 but this study has successfully generated a 3D structure for 
the query sequence using various bioinformatics tools. This 3D 
model in the future can be used to carry out in vitro and in vivo 
study of these deacetylases. Various HDAC inhibitors can be 
developed to combat cancer and other various deadly diseases. 
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